patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
Kapanol
Marketedupdated 2mo agoby Teva Pharmaceuticals USA Inc
Approvedcommunity read0 votes
all catalysts(100)
approval · 100
Sep 18, 1984
approval
DURAMORPH PF (MORPHINE SULFATE) — FDA approval
Kapanol
→
Aug 22, 1985
approval
DURAMORPH PF (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 29, 1987
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Apr 8, 1988
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 2, 1988
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
May 3, 1989
approval
DURAMORPH PF (MORPHINE SULFATE) — FDA approval
Kapanol
→
Sep 12, 1989
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Jan 16, 1990
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Apr 12, 1990
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
Jul 19, 1991
approval
DURAMORPH PF (MORPHINE SULFATE) — FDA approval
Kapanol
→
Jul 19, 1991
approval
DURAMORPH PF (MORPHINE SULFATE) — FDA approval
Kapanol
→
Nov 8, 1993
approval
MS CONTIN (MORPHINE SULFATE) — FDA approval
Kapanol
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that